LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374,761 | -66.5% | 254,940 | -27.5% | 0.00% | – |
| Q2 2023 | $1,117,817 | +92.8% | 351,515 | +43.1% | 0.00% | – |
| Q1 2023 | $579,792 | -23.7% | 245,674 | +12.2% | 0.00% | – |
| Q4 2022 | $759,541 | -75.0% | 218,888 | -47.3% | 0.00% | – |
| Q3 2022 | $3,042,000 | +115.0% | 415,089 | +91.4% | 0.00% | – |
| Q2 2022 | $1,415,000 | -21.7% | 216,894 | -39.4% | 0.00% | – |
| Q1 2022 | $1,808,000 | -76.7% | 358,040 | -64.3% | 0.00% | -100.0% |
| Q4 2021 | $7,754,000 | -2.8% | 1,001,744 | +85.9% | 0.00% | 0.0% |
| Q3 2021 | $7,978,000 | -70.2% | 539,001 | -67.3% | 0.00% | -75.0% |
| Q2 2021 | $26,745,000 | – | 1,646,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |